iRemedy Supply

05/29/2026

We're welcoming Saul Factor to the iRemedy Board of Directors. Saul spent over 30 years at the center of pharmaceutical distribution — including as President of Global Sourcing at McKesson, the largest pharma distributor in the U.S., where he scaled the North Star generics platform to $500M.

He also brings public-company board experience as an independent director of Richtech Robotics (Nasdaq: RR).

His appointment comes as iRemedy moves toward a NASDAQ listing and continues expanding across distribution, specialty biologics, pharmaceutical AI, and federal procurement.

Full press release in the link below:

Saul Factor, former McKesson Global Sourcing President who scaled North Star generics to $1.5B, joins iRemedy's Board ahead of NASDAQ listing

05/27/2026

Happy Birthday, Amanda! 🎂

Grateful to have you on the iRemedy team — here's to a great day and an even better year ahead.

05/26/2026

Honoring those who gave everything. Thank you. 🇺🇸

05/22/2026

This fraud persisted because no one had the tools to see through it. iRemedy built those tools.

iRemedy's AI platform synthesized bills of lading, UN Comtrade data, FDA regulatory filings, corporate ownership records, and peer-reviewed scientific literature across all 84 essential medicines simultaneously.

Four layers. 84 medicines. Every dependency scored and mapped.

The first assessment that shows — medicine by medicine — where the fraud is, how deep it goes, and who benefits from the concealment.

https://iremedy.com/essential-medicines

05/20/2026

🚨 iRemedy just released a first-of-its-kind AI analysis of all 84 medicines the U.S. government designates as essential.

The finding: 89% show significant dependency on Chinese supply chains — not just at the finished product level, but at the raw material level that labels are designed to hide.

• 75 of 84 essential medicines trace back to China at one or more supply chain tiers

• 31 have at least one U.S.-marketed product linked to a Chinese state-affiliated manufacturer

• 85%+ of the β-lactam antibiotic nucleus (amoxicillin, ceftriaxone) is Chinese-origin

• Only 9 of 84 medicines are structurally independent of Chinese supply chains

"The American people are being told their medicines come from trusted, diversified sources. They don't." — Tony Paquin, Founder & CEO

📰 Read the full press release:
https://www.einpresswire.com/article/913466656/iremedy-releases-ai-powered-foreign-dependency-assessment-of-america-s-essential-medicines

📊 Full report medicine by medicine:
https://iremedy.com/essential-medicines

05/15/2026

85% of amoxicillin's key chemistry originates in China. The label says India. That is pharmaceutical supply chain fraud.

iRemedy's Foreign Dependency Assessment found that the beta-lactam antibiotic family — including amoxicillin and ceftriaxone, among America's most prescribed medicines — depends on nucleus compounds that are 85% or more Chinese in origin.

Standard country-of-origin disclosures make this invisible to hospitals, pharmacies, and government buyers.

Invisible dependency is manufactured fraud.

Read the full report: https://iremedy.com/essential-medicines

iRemedy is the world’s largest and smartest procurement marketplace — powered by our patented A.I. technology.

05/14/2026

iRemedy's Foreign Dependency Assessment is now public.

89.3% of ASPR essential medicines — the drugs the U.S. government says we need most — show significant dependency on China when traced to their raw-material origins. The country-of-origin labels don't show it. Our AI does.

31 essential medicines sold in America are owned by CCP-affiliated manufacturers. Hidden by design.

This is fraud.

This is the report America needs. It's free. It's public. Share it.

Read the full assessment → https://iremedy.com/essential-medicines

05/13/2026

🎙️ New episode out now — The Hospital Finance Podcast featuring iRemedy CEO Tony Paquin.

Tony digs into the hidden costs buried in healthcare distribution: why GPO incentives work against hospitals, how the industry gave up supply chain control, and what a realistic path forward looks like.

If you work in hospital finance or supply chain, this one's worth your time.

Listen here → https://besler.holdings/what-hospital-cfos-need-to-know/

05/10/2026

Celebrating the moms today. Happy Mother's Day. 🤍

05/10/2026

Meet Scout — Debbie's pup and our unofficial office mascot. 🐶 He's been keeping us company and we are not complaining.